{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:23:32Z","timestamp":1785576212752,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202958"],"award-info":[{"award-number":["82202958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science Technology Program of Jinan","award":["202225013"],"award-info":[{"award-number":["202225013"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M734299"],"award-info":[{"award-number":["2023M734299"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Active radiation skin injury (ARSI) has the highest incidence of acute adverse reactions caused by radiotherapy (RT) in patients with head and neck cancer (HNC). This study aimed to screen risk factors that can facilitate the identification of HNC patients at high risk of ARSI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from 255 stage III-IV HNC patients who underwent intensity-modulated radiation therapy (IMRT) were collected. The data from our medical records, including clinical characteristics and hematological indices before RT, were retrospectively collected and arranged. The Common Terminology Criteria for Adverse Events Criteria (CTCAE), Radiation Therapy Oncology Group Criteria (RTOG), World Health Organization Criteria (WHO), Oncology Nursing Society (ONS), Acute Radiation Dermatitis Graduation Scale, Douglas &amp; Fowler and Radiation Dermatitis Severity Scale (RDSS) were used to assess ARSI. Of these, CTCAE was used for further analysis. Binary logistic regression analyses were used to identity risk factors. To establish the correction between each risk factor and the ARSI score, the odds ratio (OR) and 95% confidence interval (CI) were computed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The assessment results of the CTCAE with RTOG, WHO, ONS, Graduation Scale, Douglas &amp; Fowler and RDSS have good consistency. After radiotherapy, 18.4% of patients had at least 3 (3\u2009+) grade ARSI. Multivariate logistic regression analysis revealed that the KPS score, blood glucose level, white blood cell count, and plasma free thyroxine (FT4) concentration were independent risk factors for 3\u2009+\u2009grade ARSI. A nomogram was constructed on the basis of these risk factors, which demonstrated good predictive power according to the area under the ROC curve (AUC). The satisfactory consistency and clinical efficacy of the nomogram were confirmed by calibration curves and decision curve analysis (DCA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A low KPS score, high blood glucose level, high white blood cell count, and high thyroid hormone prior to radiotherapy for stage III-IV HNC are independent risk factors for grade 3\u2009+\u2009RSI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-024-03490-7","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:01:57Z","timestamp":1721894517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Acute radiation skin injury in stage III-IV head and neck cancer: scale correlates and predictive model"],"prefix":"10.1186","volume":"22","author":[{"given":"Zihan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"issue":"3","key":"3490_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1242\/dev.127.3.483","volume":"127","author":"L De Moerlooze","year":"2000","unstructured":"De Moerlooze L, Spencer-Dene B, Revest JM, Hajihosseini M, Rosewell I, Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 2000;127(3):483\u201392 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Development"},{"issue":"1","key":"3490_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2014.192","volume":"12","author":"H Kang","year":"2015","unstructured":"Kang H, Kiess A, Chung CH. Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol. 2015;12(1):11\u201326 Journal Article; Review.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"3490_CR3","first-page":"2704","volume":"113","author":"LS Elting","year":"2008","unstructured":"Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer-Am Cancer Soc. 2008;113(10):2704\u201313 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Cancer-Am Cancer Soc"},{"issue":"1","key":"3490_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12935-022-02494-1","volume":"22","author":"L Li","year":"2022","unstructured":"Li L, Li P, Zhang W, Zhou H, Guo E, Hu G, et al. FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial-mesenchymal transition and cell cycle arrest. Cancer cell int. 2022;22(1):70 Journal Article.","journal-title":"Cancer cell int"},{"issue":"1","key":"3490_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-023-01737-7","volume":"22","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Cheng L, Liu L, Li X. NK cells are never alone: crosstalk and communication in tumour microenvironments. Mol Cancer. 2023;22(1):34 Journal Article; Research Support, Non-U.S. Gov't; Review.","journal-title":"Mol Cancer"},{"issue":"1","key":"3490_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpainsymman.2019.03.017","volume":"58","author":"MA Fuzissaki","year":"2019","unstructured":"Fuzissaki MA, Paiva CE, Oliveira MA, Lajolo CP, Paiva MY. The Impact of Radiodermatitis on Breast Cancer Patients\u2019 Quality of Life During Radiotherapy: A Prospective Cohort Study. J Pain Symptom Manag. 2019;58(1):92\u20139 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"3490_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.08.024","volume":"103","author":"AK Patel","year":"2019","unstructured":"Patel AK, Ling DC, Richman AH, Champ CE, Huq MS, Heron DE, et al. Hypofractionated Whole-Breast Irradiation in Large-Breasted Women-Is There a Dosimetric Predictor for Acute Skin Toxicities? Int J Radiat Oncol. 2019;103(1):71\u20137 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"3490_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","volume":"102","author":"LJ McDowell","year":"2018","unstructured":"McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, et al. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy. Int J Radiat Oncol. 2018;102(2):340\u201352 Journal Article.","journal-title":"Int J Radiat Oncol"},{"issue":"12","key":"3490_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ASW.0000797952.41753.f4","volume":"34","author":"Z Yao","year":"2021","unstructured":"Yao Z, Cheng B. Morbidity in Patients with Nasopharyngeal Carcinoma and Radiation-Induced Skin Lesions: Cause, Risk Factors, and Dermatitis Evolution and Severity. Adv Skin Wound Care. 2021;34(12):1\u20138 Journal Article.","journal-title":"Adv Skin Wound Care"},{"key":"3490_CR10","doi-asserted-by":"publisher","first-page":"103181","DOI":"10.1016\/j.ejmp.2023.103181","volume":"116","author":"K Hamada","year":"2023","unstructured":"Hamada K, Fujibuchi T, Arakawa H, Yokoyama Y, Yoshida N, Ohura H, et al. A novel approach to predict acute radiation dermatitis in patients with head and neck cancer using a model based on Bayesian probability. Phys Medica. 2023;116.","journal-title":"Phys Medica"},{"key":"3490_CR11","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.2147\/JIR.S318812","volume":"14","author":"AO Smith","year":"2021","unstructured":"Smith AO, Ju W, Adzraku SY, Wenyi L, Yuting C, Qiao J, et al. Gamma Radiation Induce Inflammasome Signaling and Pyroptosis in Microvascular Endothelial Cells. J Inflamm Res. 2021;14:3277\u201388 Journal Article.","journal-title":"J Inflamm Res"},{"issue":"1","key":"3490_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12885-023-10821-6","volume":"23","author":"Y Xie","year":"2023","unstructured":"Xie Y, Hu T, Chen R, Chang H, Wang Q, Cheng J. Predicting acute radiation dermatitis in breast cancer: a prospective cohort study. BMC Cancer. 2023;23(1):537 Journal Article.","journal-title":"BMC Cancer"},{"issue":"8","key":"3490_CR13","doi-asserted-by":"publisher","first-page":"e10207","DOI":"10.1016\/j.heliyon.2022.e10207","volume":"8","author":"YN Wang","year":"2022","unstructured":"Wang YN, Zou M, Wang D, Zhang ZK, Qu LP, Xu J, et al. An exploratory study on TCM syndrome differentiation in preoperative patients with colorectal cancer assisted by laboratory indicators. Heliyon. 2022;8(8):e10207.","journal-title":"Heliyon"},{"issue":"9","key":"3490_CR14","first-page":"1992","volume":"112","author":"M Sorror","year":"2008","unstructured":"Sorror M, Storer B, Sandmaier BM, Maloney DG, Chauncey TR, Langston A, et al. Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer-Am Cancer Soc. 2008;112(9):1992\u20132001 Journal Article; Research Support, N.I.H., Extramural.","journal-title":"Cancer-Am Cancer Soc"},{"issue":"6","key":"3490_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New Engl J Med. 2006;354(6):567\u201378 Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't.","journal-title":"New Engl J Med"},{"issue":"6","key":"3490_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00066-011-2217-7","volume":"187","author":"E Selzer","year":"2011","unstructured":"Selzer E, Liederer S, Lemaire C, Kren G, Radonjic D, Kornek G, et al. Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab. Strahlenther Onkol. 2011;187(6):373\u20137 Journal Article.","journal-title":"Strahlenther Onkol"},{"issue":"7\u20138","key":"3490_CR17","first-page":"239","volume":"106","author":"DA Nelson","year":"1993","unstructured":"Nelson DA, Floren Y. Left-sided delivery position according to Simm\u2019s method. Jordemodern. 1993;106(7\u20138):239\u201342 Journal Article.","journal-title":"Jordemodern."},{"issue":"5","key":"3490_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMc071075","volume":"357","author":"W Budach","year":"2007","unstructured":"Budach W, Bolke E, Homey B. Severe cutaneous reaction during radiation therapy with concurrent cetuximab. New Engl J Med. 2007;357(5):514\u20135 Letter.","journal-title":"New Engl J Med"},{"issue":"4","key":"3490_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0889-8529(05)70359-5","volume":"25","author":"DW Harsha","year":"1996","unstructured":"Harsha DW, Bray GA. Body composition and childhood obesity. Endocrin Metab Clin. 1996;25(4):871\u201385 Journal Article; Review.","journal-title":"Endocrin Metab Clin"},{"issue":"3","key":"3490_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/annonc\/mdq412","volume":"22","author":"M Merlano","year":"2011","unstructured":"Merlano M, Russi E, Benasso M, Corvo R, Colantonio I, Vigna-Taglianti R, et al. Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Ann Oncol. 2011;22(3):712\u20137 Clinical Trial, Phase II; Journal Article.","journal-title":"Ann Oncol"},{"issue":"10","key":"3490_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/annonc\/mdr139","volume":"22","author":"J Bernier","year":"2011","unstructured":"Bernier J, Russi EG, Homey B, Merlano MC, Mesia R, Peyrade F, et al. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. Ann Oncol. 2011;22(10):2191\u2013200 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Ann Oncol"},{"issue":"6","key":"3490_CR22","first-page":"2166","volume":"6","author":"SM Huang","year":"2000","unstructured":"Huang SM, Harari PM. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. CLIN CANCER RES. 2000;6(6):2166\u201374 Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.","journal-title":"CLIN CANCER RES."},{"issue":"6","key":"3490_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/ijd.13507","volume":"56","author":"M Villavicencio","year":"2017","unstructured":"Villavicencio M, Granados-Garcia M, Vilajosana E, Dominguez-Cherit J. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck. Int J Dermatol. 2017;56(6):602\u20139 Journal Article; Review.","journal-title":"Int J Dermatol"},{"issue":"1","key":"3490_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12888-023-04760-6","volume":"23","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li B, Guo X, Bai W, Kou C. The association between schizophrenia and white blood cells count: a bidirectional two-sample Mendelian randomization study. BMC PSYCHIATRY. 2023;23(1):271 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"BMC PSYCHIATRY."},{"issue":"20","key":"3490_CR25","doi-asserted-by":"publisher","first-page":"e33825","DOI":"10.1097\/MD.0000000000033825","volume":"102","author":"X Hou","year":"2023","unstructured":"Hou X, Chen D, Wang Y, Cui B, Xu H, Wang Y, et al. Network analysis to explore the pharmacological mechanism of Shenmai injection in treating granulocytopenia and evidence-based medicine approach validation. Medicine. 2023;102(20):e33825 Journal Article; Meta-Analysis.","journal-title":"Medicine"},{"issue":"4","key":"3490_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1074-7613(02)00424-7","volume":"17","author":"CL Semerad","year":"2002","unstructured":"Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 2002;17(4):413\u201323 Journal Article; Research Support, U.S. Gov't, P.H.S.","journal-title":"Immunity"},{"issue":"2","key":"3490_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/idoj.idoj_226_21","volume":"13","author":"V Gaurav","year":"2022","unstructured":"Gaurav V, Grover C. Pseudotumors in Dermatology. Indian Dermatol Onl. 2022;13(2):294\u2013301 Journal Article.","journal-title":"Indian Dermatol Onl"},{"issue":"7","key":"3490_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCRESAHA.108.182899","volume":"103","author":"M Mahmoudi","year":"2008","unstructured":"Mahmoudi M, Gorenne I, Mercer J, Figg N, Littlewood T, Bennett M. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res. 2008;103(7):717\u201325 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Circ Res"},{"key":"3490_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bmb\/ldq044","volume":"97","author":"G Fritz","year":"2011","unstructured":"Fritz G, Henninger C, Huelsenbeck J. Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents. Brit Med Bull. 2011;97:17\u201326 Journal Article; Research Support, Non-U.S. Gov't; Review.","journal-title":"Brit Med Bull"},{"issue":"1","key":"3490_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1871525717666190524092918","volume":"17","author":"M Pouri","year":"2019","unstructured":"Pouri M, Shaghaghi Z, Ghasemi A, Hosseinimehr SJ. Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes. Cardiovasc Hematol Agents Med Chem. 2019;17(1):40\u20136 Journal Article.","journal-title":"Cardiovasc Hematol Agents Med Chem."},{"key":"3490_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mrgentox.2016.09.001","volume":"809","author":"M Cheki","year":"2016","unstructured":"Cheki M, Shirazi A, Mahmoudzadeh A, Bazzaz JT, Hosseinimehr SJ. The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes. Mutat Res-Gen Tox En. 2016;809:24\u201332 Journal Article.","journal-title":"Mutat Res-Gen Tox En"},{"issue":"2","key":"3490_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148\u201359 Journal Article; Research Support, Non-U.S. Gov'; Review.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3490_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1677\/joe.1.05968","volume":"185","author":"E Mezosi","year":"2005","unstructured":"Mezosi E, Szabo J, Nagy EV, Borbely A, Varga E, Paragh G, et al. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol. 2005;185(1):121\u20139 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"J Endocrinol"},{"issue":"5","key":"3490_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/thy.2010.0183","volume":"21","author":"M Dedecjus","year":"2011","unstructured":"Dedecjus M, Stasiolek M, Brzezinski J, Selmaj K, Lewinski A. Thyroid hormones influence human dendritic cells\u2019 phenotype, function, and subsets distribution. Thyroid. 2011;21(5):533\u201340 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Thyroid"},{"issue":"2","key":"3490_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5603\/FHC.2014.0013","volume":"52","author":"M Stasiolek","year":"2014","unstructured":"Stasiolek M, Dedecjus M, Adamczewski Z, Sliwka PW, Brzezinski J, Lewinski A. Effect of L-thyroxine treatment on peripheral blood dendritic cell subpopulations in patients with Hashimoto\u2019s thyroiditis. Folia Histochem Cyto. 2014;52(2):138\u201343 Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Folia Histochem Cyto"},{"issue":"4","key":"3490_CR36","first-page":"226","volume":"10","author":"M Provinciali","year":"1991","unstructured":"Provinciali M, Muzzioli M, Di Stefano G, Fabris N. Recovery of spleen cell natural killer activity by thyroid hormone treatment in old mice. Nat Immun Cell Growth Regul. 1991;10(4):226\u201336 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"Nat Immun Cell Growth Regul."},{"issue":"2","key":"3490_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF03349536","volume":"13","author":"M Provinciali","year":"1990","unstructured":"Provinciali M, Fabris N. Modulation of lymphoid cell sensitivity to interferon by thyroid hormones. J Endocrinol Invest. 1990;13(2):187\u201391 Journal Article.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"3490_CR38","first-page":"617","volume":"3","author":"M Provinciali","year":"1987","unstructured":"Provinciali M, Muzzioli M, Fabris N. Thyroxine-dependent modulation of natural killer activity. J Exp Pathol. 1987;3(4):617\u201322 Journal Article.","journal-title":"J Exp Pathol."},{"issue":"3","key":"3490_CR39","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1152\/jappl.1996.80.3.899","volume":"80","author":"MA Forner","year":"1996","unstructured":"Forner MA, Barriga C, Ortega E. Exercise-induced stimulation of murine macrophage phagocytosis may be mediated by thyroxine. J Appl Physiol. 1996;80(3):899\u2013903 Journal Article; Research Support, Non-U.S. Gov't.","journal-title":"J Appl Physiol"},{"key":"3490_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fendo.2019.00350","volume":"10","author":"M Montesinos","year":"2019","unstructured":"Montesinos M, Pellizas CG. Thyroid Hormone Action on Innate Immunity. Front Endocrinol. 2019;10:350 Journal Article; Review.","journal-title":"Front Endocrinol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03490-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:04:26Z","timestamp":1721894666000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03490-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3490"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03490-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was approved by the Institutional Review Board of Shandong Cancer Hospital and Institute (approval number SDTHEC2024004013). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}],"article-number":"195"}}